Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/15/2009US20090258019 Diagnosis of carcinoma using RAIG1 polypeptides
10/15/2009US20090258016 Substituted imidazole derivatives
10/15/2009US20090258015 Modulators of Candida Hyphal Morphogenesis and Uses Thereof
10/15/2009US20090258006 Method of modulating neovascularization
10/15/2009US20090258000 Mucosally non-irritative amphotericin b formulations and methods for treating non-invasive fungus-induced mucositis
10/15/2009US20090257999 Method of preventing contrast-induced nephropathy
10/15/2009US20090257998 Method for treating heart attacks, strokes and diabetic crisis by utilizing modified virus virions to insert necessary protein molecules and vital nutrients into targeted cells
10/15/2009US20090257997 Stable Aqueous Compositions Comprising Bioactive Creatine Species
10/15/2009US20090257996 Dietary supplement energy-providing to skeletal muscles and protecting the cardio vascular tract
10/15/2009US20090257984 Antifungal compositions containing the endophyte fungus alternaria alternata and or its metabolites, as antagonist agents of plasmopara viticola
10/15/2009US20090257983 Medical treatment device for treating aids by utilizing modified human immunodeficiency virus virions to insert anti-viral medications into t-helper cells
10/15/2009US20090257980 Anti-virus therapy for respiratory diseases
10/15/2009US20090257979 Novel Inhibitors of Hepatitis C Virus Replication
10/15/2009US20090257977 Novel tetrahydropyridothiophenes
10/15/2009US20090257976 Single vial formulation for medical grade cyanoacrylate
10/15/2009US20090257972 Cosmetic and dermatological compositions in particular for the treatment of keratin containing substrates
10/15/2009US20090257969 Soft anticholinergic zwitterions
10/15/2009US20090257968 Gels containing anionic surfactants and coupling agents
10/15/2009US20090257967 Compositions comprising sugar beet pectin and carotenoids
10/15/2009US20090257965 Abnormal protein removing composition
10/15/2009US20090257959 Pesticidal compositions
10/15/2009US20090257953 Novel fluorine-18 labeled rhodamine derivatives for myocardial perfusion imaging with positron emission tomography
10/15/2009US20090257951 NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same
10/15/2009US20090257950 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports
10/15/2009DE202008003509U1 Pharmazeutische Zusammensetzung zur Prophylaxe und Behandlung der Arteriosklerose, sowie zur Schmerzbekämpfung und zur Entzündungshemmung A pharmaceutical composition for the prophylaxis and treatment of atherosclerosis, as well as pain relief and inflammation
10/15/2009DE102008018675A1 Oxo-heterocyclisch substituierte Carbonsäure-Derivate und ihre Verwendung Oxo-substituted heterocyclic carboxylic acid derivatives and their use
10/15/2009DE102008017853A1 Thienopyrimidine Thienopyrimidines
10/15/2009DE102008017496A1 New boswellic acid derivatives are microsomal prostaglandin E-1 synthesis inhibitors, useful to treat e.g. rheumatoid arthritis, inflammatory bowel disease, asthma, feverish and painful conditions, cancers, emphysema and multiple sclerosis
10/15/2009DE102008015607A1 New boswellic acid derivatives are microsomal prostaglandin E-1 synthesis inhibitors, useful to treat e.g. rheumatoid arthritis, inflammatory bowel disease, asthma, feverish and painful conditions, cancers, emphysema and multiple sclerosis
10/15/2009DE102008011800A1 Orally disintegrating film, useful e.g. to combat parasites in animals, preferably fish, exotic or wild animals, comprises a matrix made of a polymer of modified pea starch and an antiparasitic agent e.g. ivermectin and selamectin
10/15/2009CA2725822A1 Pharmaceutical depot comprising n-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl}-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
10/15/2009CA2725425A1 Homocysteine synthase inhibitor
10/15/2009CA2725390A1 Use of a hdac inhibitor and a her-2 inhibitor in the treatment of breast cancer
10/15/2009CA2721346A1 Bis-aromatic anticancer agents
10/15/2009CA2721183A1 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
10/15/2009CA2721163A1 Macrocyclic compounds and methods of treatment
10/15/2009CA2721153A1 Compositions of hydrophobic taxane derivatives and uses thereof
10/15/2009CA2721140A1 Tetracyclic anthraquinone antibiotic derivatives with high activity, process for preparing the same and use thereof
10/15/2009CA2721119A1 Anhydrous crystal form of orvepitant maleate
10/15/2009CA2721115A1 Tablet comprising eprosartan mesylate
10/15/2009CA2721099A1 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase
10/15/2009CA2721082A1 Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation
10/15/2009CA2721071A1 Methods and use of inducing apoptosis in cancer cells
10/15/2009CA2721060A1 Inhibitors of fatty acid amide hydrolase
10/15/2009CA2721051A1 Aminosugar compound and process for production thereof
10/15/2009CA2721044A1 Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these
10/15/2009CA2721031A1 Novel (pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal for treatment of cancer and other diseases
10/15/2009CA2721025A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
10/15/2009CA2721014A1 Aqueous pharmaceutical formulation
10/15/2009CA2720950A1 Compounds and compositions as modulators of gpr119 activity
10/15/2009CA2720946A1 Compounds and compositions as protein kinase inhibitors
10/15/2009CA2720887A1 Inhibitors of stim1 for the treatment of cardiovascular disorders
10/15/2009CA2720879A1 Substituted sulfonamide derivatives
10/15/2009CA2720878A1 Thienopyrimidines
10/15/2009CA2720865A1 Process for preparation of amine polymer salt
10/15/2009CA2720793A1 Substituted sulfonamide derivatives
10/15/2009CA2720771A1 Triterpene saponins, methods of synthesis, and uses thereof
10/15/2009CA2720744A1 Granulation of active pharmaceutical ingredients
10/15/2009CA2720735A1 Substituted sulfonamide derivatives
10/15/2009CA2720721A1 Combination therapy for the treatment of bacterial infections
10/15/2009CA2720686A1 Fused ring compounds and use thereof
10/15/2009CA2720613A1 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
10/15/2009CA2720592A1 Single dosage pharmaceutical formulation comprising eprosartan mesylate
10/15/2009CA2720586A1 Glucopyranoside derivatives
10/15/2009CA2720552A1 Acylthiourea compound or salt thereof, and use thereof
10/15/2009CA2720547A1 New combination for use in the treatment of inflammatory disorders
10/15/2009CA2720530A1 Sulfonamides
10/15/2009CA2720096A1 Pai-1 inhibitor
10/15/2009CA2719924A1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
10/15/2009CA2719650A1 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
10/15/2009CA2719636A1 Substituted 2-phenyl-pyridine derivatives
10/15/2009CA2719569A1 2-phenyl-4-cyclopropyl-pyrimidine derivatives
10/15/2009CA2719538A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
10/15/2009CA2719440A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophy
10/15/2009CA2719376A1 2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors
10/15/2009CA2719364A1 Butenafine hydrochloride-containing aqueous patch
10/15/2009CA2718544A1 Crystalline salt forms of antifolate compounds and methods of manufacturing thereof
10/15/2009CA2718330A1 Antifolate compositions
10/15/2009CA2716202A1 Pyrrolo[2,3-d]pyrimidin-2-yl-amine derivatives as pkc-theta inhibitors
10/15/2009CA2711212A1 Treatment of migraines without aura in pregnant women by inhalation of dioxygen gas
10/15/2009CA2662636A1 N-acetylcysteine compositions and methods for treating acute exacerbations of inflammatory lung disease
10/14/2009EP2108661A1 Metal salt of crosslinked cellulose derivative
10/14/2009EP2108652A2 Process for the preparation of drospirenone
10/14/2009EP2108651A1 Crystalline form I of 2-methyl-4-(4-methyl-1-piperazinyl) 10H thieno[2,3-B][1,5] benzodiazepine
10/14/2009EP2108649A1 Novel indol carboxylic acid bispyridyl carboxamide derivatives as 5-HT2c receptor antagonists
10/14/2009EP2108648A1 Selected CGRP antagonists, method for their manufacture and use as medicines
10/14/2009EP2108645A1 Use of xanthone derivatives as a medicament for cancer
10/14/2009EP2108644A1 N-(methyl)-pyridin-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins
10/14/2009EP2108643A1 4-methyl-4, 5-dihydro-1H-pyrazole-3-carboxamide useful as a cannabinoid CB1 neutral antagonist
10/14/2009EP2108642A1 Jak inhibitor
10/14/2009EP2108641A1 New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
10/14/2009EP2108404A1 Anti-bacterial extracts from mammea americana and marchantia polymorpha
10/14/2009EP2108377A1 Vascularization inhibitors
10/14/2009EP2108373A1 Treatment of tumor metastases
10/14/2009EP2108371A1 Estra-1,3,5(10)-trie derivatives for contraception
10/14/2009EP2108370A1 Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
10/14/2009EP2108369A1 Compounds for the treatment of immunosuppression in the skin caused by aggressive agents
10/14/2009EP2108368A1 Poly(glutamic acid)-drug conjugate with an amino acid as a linker
10/14/2009EP2108367A1 Composition for amelioration/prevention of adverse side effect in steroid therapy
10/14/2009EP2108366A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophy
1 ... 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 ... 7860